Topical Bromfenac for Intraoperative Miosis and Pain Reduction

• Status: Unknown status
• Trial end date: 2019-03-30
• Target enrollment: 0
• Participant gender: All

Summary

To evaluate the effect of bromfenac ophthalmic solution 0.09% for reduction of intraoperative miosis and pain in patient who have undergone femtosecond laser-assisted cataract surgery.

• Phase: Phase 4
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Hospital de La Luz
• Treatments: Bromfenac; Hyaluronic Acid

Criteria

Inclusion Criteria:

• Male and female

• Subjects 18 years or older

• Patients scheduled for unilateral femtosecond laser-assisted cataract surgery cataract surgery with posterior chamber (PC) IOL implantation.

Exclusion Criteria:

• Presence of corneal abnormalities

• History of intraocular surgery

• History of ocular or systematic diseases (glaucoma, diabetes, uveitis

• Regular, systemic use of steroid or NSAIDs during the previous 3 months